A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial Participants

Part of paid clinical trials in Newport Beach, California.

Sponsor
Bausch & Lomb Incorporated
Study ID
NCT07717918
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Healthy

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • BL1332 eye drops — DRUG
    Taken 1 time
  • BL1332 Placebo eye drops — DRUG
    Taken 1 time

Study Details

Single center, double-masked study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Subjects

Key Dates

First listed
Jul 21, 2026
Start date
Jul 6, 2026
Status verified
Jul 2026
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
28 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Active Comparator: BL1332 eye drops
  • Placebo Comparator: BL1332 Placebo eye drops

Primary Outcome Measure

Ocular pain severity assessed by numeric pain rating scale (NPRS) [ Time Frame: Assessed 5 seconds post-capsaicin dose ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Site 101Newport BeachCalifornia92663-

Related Studies